Gilbert M. Rishton

2.7k total citations
17 papers, 1.5k citations indexed

About

Gilbert M. Rishton is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Gilbert M. Rishton has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 5 papers in Oncology. Recurrent topics in Gilbert M. Rishton's work include Computational Drug Discovery Methods (6 papers), Chemical Synthesis and Analysis (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Gilbert M. Rishton is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Chemical Synthesis and Analysis (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Gilbert M. Rishton collaborates with scholars based in United States, Sweden and Germany. Gilbert M. Rishton's co-authors include Larry E. Overman, J Scherrer, Edward F. Nemeth, Manuel F. Balandrin, Michael A. Miller, Haynes Heaton, Edward Shatzen, John Fox, David L. Lacey and Bradford C. Van Wagenen and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Gilbert M. Rishton

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilbert M. Rishton United States 15 754 450 323 200 191 17 1.5k
Michael D. Aleo United States 24 694 0.9× 343 0.8× 139 0.4× 103 0.5× 73 0.4× 51 2.0k
Marina Naldi Italy 24 606 0.8× 228 0.5× 228 0.7× 352 1.8× 32 0.2× 73 1.5k
Brett Lomenick United States 13 1.3k 1.7× 204 0.5× 182 0.6× 176 0.9× 29 0.2× 27 1.9k
Zhili Zuo China 25 796 1.1× 226 0.5× 378 1.2× 460 2.3× 21 0.1× 101 1.8k
Chenzhong Liao China 29 1.5k 1.9× 357 0.8× 530 1.6× 174 0.9× 16 0.1× 107 2.5k
Alessandra Pani Italy 26 785 1.0× 74 0.2× 606 1.9× 78 0.4× 57 0.3× 86 2.1k
Linli Li China 26 1.2k 1.6× 550 1.2× 444 1.4× 149 0.7× 19 0.1× 111 2.0k
Juan Sun China 26 699 0.9× 143 0.3× 1.2k 3.6× 188 0.9× 39 0.2× 106 2.2k
Harbinder Singh India 24 542 0.7× 138 0.3× 826 2.6× 189 0.9× 260 1.4× 52 1.6k
Mariette Robbi Belgium 15 1.3k 1.7× 181 0.4× 66 0.2× 303 1.5× 24 0.1× 22 2.1k

Countries citing papers authored by Gilbert M. Rishton

Since Specialization
Citations

This map shows the geographic impact of Gilbert M. Rishton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert M. Rishton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert M. Rishton more than expected).

Fields of papers citing papers by Gilbert M. Rishton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert M. Rishton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert M. Rishton. The network helps show where Gilbert M. Rishton may publish in the future.

Co-authorship network of co-authors of Gilbert M. Rishton

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert M. Rishton. A scholar is included among the top collaborators of Gilbert M. Rishton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert M. Rishton. Gilbert M. Rishton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yurko, Raymond, Nicholas J. Izzo, Courtney Rehak, et al.. (2021). Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein. Journal of Neuroscience Research. 99(4). 1161–1176. 33 indexed citations
2.
Rishton, Gilbert M., Gary C. Look, Zhi‐Jie Ni, et al.. (2021). Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease. ACS Medicinal Chemistry Letters. 12(9). 1389–1395. 31 indexed citations
3.
Oprea, Tudor I., Cristian Bologa, Scott Boyer, et al.. (2009). A crowdsourcing evaluation of the NIH chemical probes. Nature Chemical Biology. 5(7). 441–447. 85 indexed citations
4.
Rishton, Gilbert M.. (2008). Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening. Current Opinion in Chemical Biology. 12(3). 340–351. 29 indexed citations
5.
Rishton, Gilbert M.. (2008). Natural Products as a Robust Source of New Drugs and Drug Leads: Past Successes and Present Day Issues. The American Journal of Cardiology. 101(10). S43–S49. 183 indexed citations
6.
Rishton, Gilbert M.. (2008). Small Molecules that Promote Neurogenesis in vitro. PubMed. 3(3). 200–208. 20 indexed citations
7.
Rishton, Gilbert M., et al.. (2006). Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer's disease.. PubMed. 9(3). 303–13. 29 indexed citations
8.
9.
Nemeth, Edward F., Haynes Heaton, Michael A. Miller, et al.. (2004). Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl. Journal of Pharmacology and Experimental Therapeutics. 308(2). 627–635. 286 indexed citations
10.
Rishton, Gilbert M.. (2003). Nonleadlikeness and leadlikeness in biochemical screening. Drug Discovery Today. 8(2). 86–96. 281 indexed citations
11.
Rishton, Gilbert M., Paul Tempest, James Novotny, et al.. (2000). Fenchylamine Sulfonamide Inhibitors of Amyloid β Peptide Production by the γ-Secretase Proteolytic Pathway:  Potential Small-Molecule Therapeutic Agents for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 43(12). 2297–2299. 51 indexed citations
12.
Rishton, Gilbert M.. (1997). Reactive compounds and in vitro false positives in HTS. Drug Discovery Today. 2(9). 382–384. 259 indexed citations
13.
Poon, Betty, Jeremy B. M. Jowett, Sheila A. Stewart, et al.. (1997). Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. Journal of Virology. 71(5). 3961–3971. 78 indexed citations
14.
Rishton, Gilbert M., et al.. (1996). A ?-turn mimic and a thiomethylene dipeptide surrogate employed in the study of cyclic peptide RGD and RCD cell-adhesion inhibitors. Letters in Peptide Science. 3(1). 37–44. 1 indexed citations
15.
Harn, Nancy K., et al.. (1994). Arg-Gly thiomethylene dipeptide surrogates: Synthesis and incorporation into Arg-Gly-Asp pseudotripeptides. Tetrahedron Letters. 35(9). 1389–1392. 4 indexed citations
16.
Overman, Larry E., et al.. (1991). Stereocontrolled preparation of tetrahydrofurans from acid-promoted rearrangements of allylic acetals. Journal of the American Chemical Society. 113(14). 5354–5365. 58 indexed citations
17.
Rishton, Gilbert M., et al.. (1988). Acid-catalyzed cyclizations of aromatic diazoacetamides; synthesis of spirodienone lactams, isoquinolinones. and benzazepinones. Tetrahedron Letters. 29(22). 2643–2646. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael D. Aleo Breakdown of academic impact, for papers by Marina Naldi Breakdown of academic impact, for papers by Brett Lomenick Breakdown of academic impact, for papers by Zhili Zuo Breakdown of academic impact, for papers by Chenzhong Liao Breakdown of academic impact, for papers by Alessandra Pani Breakdown of academic impact, for papers by Linli Li Breakdown of academic impact, for papers by Juan Sun Breakdown of academic impact, for papers by Harbinder Singh Breakdown of academic impact, for papers by Mariette Robbi
Rankless by CCL
2026